All In Biotech

Drug Trial Radar · NCT07764627

Study of SG301 for Renal AMR After Transplantation

A Phase II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Efficacy of SG301 Injection in Patients With Antibody-Mediated Rejection (AMR) After Renal Transplantation

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Dec 1, 2026

Primary completion

Mar 31, 2027

Study completion Jun 30, 2028

Sponsor

Sponsor type
Industry
First posted
Aug 14, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and tolerability of SG301 injection in patients with antibody-mediated rejection (AMR) after renal transplantation.

Conditions

  • Antibody Mediated Rejection

Interventions

  • SG301 InjectionDrug

    Dosage form: solution for infusion; Route of administration: intravenous; Frequency: weekly intervals (QW) for 4 weeks, then every 4 weeks (Q4W) for 48 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. safety eventsTime frame: Up to Week 52

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China

  • The Second Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

  • First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)

    Jinan, Shandong, China

  • West China Hospital,Sichuan University

    Chengdu, Sichuan, China

  • Shulan(Hang Zhou) Hospital

    Hangzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.